title: Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy.
abstract: Abciximab has a key role in the treatment of patients with acute coronary syndromes undergoing percutaneous coronary intervention; however, an increased risk of bleeding complications is well recognized. We report a case of serious pulmonary hemorrhage after use of abciximab therapy. A definitive indication and treatment guideline should be available to minimize serious bleeding complications. Additionally, respiratory symptoms should be monitored closely for early detection of serious pulmonary hemorrhage in patients receiving abciximab therapy during percutaneous coronary intervention.
authors.affiliation: Yoorimbin@hanmail.net
authors.forename: Rak Kyeong
authors.initials: RK
authors.lastname: Choi
authors.forename: Nae Hee
authors.initials: NH
authors.lastname: Lee
authors.forename: Dal Soo
authors.initials: DS
authors.lastname: Lim
authors.forename: Suk keun
authors.initials: Sk
authors.lastname: Hong
authors.forename: Hweung Kon
authors.initials: HK
authors.lastname: Hwang
mesh_terms: D000077284:Abciximab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D008171:Lung Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011859:Radiography
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab